Bleomycin and misonidazole cytotoxicity.

por Korbelik, M., Palcic, B., Skarsgard, L. D.
Publicado 1985

In vitro metabolism of misonidazole.

por Josephy, P. D., Palcic, B., Skarsgard, L. D.
Publicado 1981

Survival measurements at low doses: oxygen enhancement ratio.

por Palcic, B., Brosing, J. W., Skarsgard, L. D.
Publicado 1982

The effect of pH on the aerobic and hypoxic cytotoxicity of SR4233 in HT-29 cells.

por Skarsgard, L. D., Skwarchuk, M. W., Vinczan, A., Chaplin, D. J.
Publicado 1993

Recent Developments at the $\mu$ Meson Radiotherapy Facility at TRIUMF

por Henkelman, M R, Skarsgard, L D, Lam, K Y, Harrison, R W, Palcic, B
Publicado 1976

Cytotoxic effect of RB 6145 in human tumour cell lines: dependence on hypoxia, extra- and intracellular pH and drug uptake.

por Skarsgard, L. D., Acheson, D. K., Vinczan, A., Wouters, B. G., Heinrichs, B. E., Loblaw, D. A., Minchinton, A. I., Chaplin, D. J.
Publicado 1995

Progress during the first year of operation of the Batho biomedical facility at TRIUMF: Oct 1976

por Henkelman, R M, Lam, K Y, Harrison, R W, Shortt, K R, Poon, M Y, Lang, H, Jaggi, B W, Palcic, B, Skarsgard, L D
Publicado 1977

Biological effectiveness of antiproton annihilation

por Maggiore, C J, Agazaryan, N, Bassler, N, Blackmore, E, Beyer, G, De Marco, J J, Doser, Michael, Gruhn, Charles R, Holzscheiter, M H, Ichioka, T, Iwamoto, K S, Knudsen, H V, Landua, Rolf, McBride, W H, Møller, S P, Petersen, J, Smathers, J B, Skarsgard, L D, Solberg, T, Uggerhøj, U, Withers, H R, Wouters, B G
Publicado 2004